XML 37 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 27, 2015
Jun. 28, 2014
Operating activities:    
Net earnings $ 50,355,000 $ 49,625,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of fixed assets 24,013,000 23,599,000
Amortization of intangibles and deferred costs 4,445,000 3,929,000
Share-based compensation 1,625,000 1,638,000
Deferred income taxes (131,000) (257,000)
Loss on sale of marketable securities 1,904,000 361,000
Other (255,000) (205,000)
Changes in assets and liabilities net of effects from purchase of companies    
Increase in accounts receivable (15,821,000) (17,390,000)
Increase in inventories (5,998,000) (6,320,000)
Increase in prepaid expenses (511,000) (262,000)
Increase in accounts payable and accrued liabilities 8,980,000 14,417,000
Net cash provided by operating activities 68,606,000 69,135,000
Investing activities:    
Payment for purchases of companies, net of cash acquired (615,000) (28,528,000)
Purchases of property, plant and equipment (36,234,000) (31,346,000)
Purchases of marketable securities (16,126,000) (26,932,000)
Proceeds from redemption and sales of marketable securities 39,968,000 7,245,000
Proceeds from disposal of property and equipment 1,322,000 1,241,000
Other (167,000) (408,000)
Net cash used in investing activities (11,852,000) (78,728,000)
Financing activities:    
Payments to repurchase common stock (2,114,000) (5,903,000)
Proceeds from issuance of stock 2,174,000 1,107,000
Payments on capitalized lease obligations (176,000) (273,000)
Payment of cash dividend (19,425,000) (14,949,000)
Net cash used in financing activities (19,541,000) (20,018,000)
Effect of exchange rate on cash and cash equivalents (2,425,000) 20,000
Net increase (decrease) in cash and cash equivalents 34,788,000 (29,591,000)
Cash and cash equivalents at beginning of period 91,760,000 97,345,000
Cash and cash equivalents at end of period $ 126,548,000 $ 67,754,000